Investing in growth stocks through a simple buy-and-hold strategy can yield great returns without the need to pick individual stocks.
Validea’s guru fundamental report for PHILIP MORRIS INTERNATIONAL INC. (PM) shows that the stock rates highest using the Multi-Factor Investor
MicroStrategy (MSTR) stock has soared nearly 4,000% in the past five years as the company’s Bitcoin holdings continue to drive
President Trump is considering removing Federal Reserve chairman Jerome Powell, which analysts warn could cost the government $58 billion in
OpenAI CEO Sam Altman recently attended the AI Revolution Forum in Taipei. Altman, a prominent figure in AI, shared his
The second-quarter earnings season is in full swing, with strong consumer performance boosting corporate profits. However, stock market reactions have
Nvidia is a key player in the AI race, focusing on innovative products to maintain its leading position. While not
Headlines in the electric vehicle (EV) stock market are focused on Tesla’s robotaxi launch in Austin, Texas. Meanwhile, Lucid Group
President Donald Trump’s second term is marked by a focus on cutting Federal spending, including healthcare funding. Despite the economic
Savings interest rates are falling due to the Federal Reserve cutting its target rate three times in late 2024. The
Validea’s Growth/Value Investor model has upgraded EASTMAN CHEMICAL CO (EMN) to a 100% rating in the Chemical Manufacturing industry. The
Real estate investment trusts (REITs) like Simon Property Group (NYSE: SPG) and Federal Realty Investment Trust (NYSE: FRT) can be
The “Magnificent Seven” tech stocks, known for their AI prowess, are facing challenges as investor expectations rise. Netflix, a notable
Social Security undergoes changes annually, with the potential for a 2.6% cost-of-living adjustment in 2026. High earners may see an
In 2025, the S&P 500, Dow Jones Industrial Average, and Nasdaq Composite have experienced significant volatility due to various catalysts,
Piper Sandler analyst Derek Podhaizer initiated coverage of Liberty Energy Inc. (NYSE:LBRT) with a “Neutral” rating and a price target
Deutsche Bank downgraded Venture Global, Inc. (VG) stock to “Hold” from “Buy” with a price target of $17 due to
Block Inc. will replace Hess Corp. in the S&P 500 on July 23, following Chevron Corp.’s acquisition of Hess Corp.
Iridium Communications (NASDAQ:IRDM) receives a $40 price target from Cantor Fitzgerald ahead of its Q2 earnings, citing reliable profitability, strong
Thomson Reuters Corp will join the Nasdaq-100 Index and Nasdaq-100 Equal Weighted Index on July 28, 2025, replacing ANSYS, Inc.
Pfizer Inc. (NYSE:PFE) is among the 14 Best Pharma Dividend Stocks to Buy in 2025. Despite recent stock declines, Pfizer’s
AbbVie Inc. (NYSE:ABBV) is listed among the 14 Best Pharma Dividend Stocks to Buy in 2025. The company is a
Amcon Distributing reported a 3.0% increase in revenue to $739.6 million in Q3 fiscal 2025, but saw a decline in
McKesson Corporation (NYSE:MCK) is among the 14 Best Pharma Dividend Stocks to Buy in 2025. In its Q4 2025 earnings
Ally Financial reported adjusted EPS of $0.99 for Q2 2025, beating estimates by 22% and marking a 36% increase from
